Trending News

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

In Case You Missed It: DOL Prohibited From Collecting Liquidated Damages in Wage & Hour Pre-Litigation Investigations

SEC’s New Concept Release on Foreign Private Issuer Standards

What Regulated Businesses Should Know About the Supreme Court’s Recent NEPA Decision

NEW ATDS BATTLEGROUND: Texas Passes HUGE NEW AMENDMENT to Its State Telemarketing Law Reviving The Risk of Autodialer Cases

Supreme Court Eliminates Heightened Discrimination Standard Under Title VII

Cleaning the Cupboard—Six More Decisions in One Day, and a Largely Harmonious Court - SCOTUS Today

U.S. Supreme Court Holds Majority-Group Plaintiffs Are Not Subject to a Heightened Evidentiary Standard Under Title VII

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Verrica Pharmaceuticals Reports Strong Growth in YCANTH® Dispensed Applicator Units in 2Q 2025
Posted On Wednesday, July 09, 2025
Nusano Achieves Key Technology Milestone Enabling Simultaneous Production of Multiple Radioisotopes
Posted On Wednesday, July 09, 2025
Arvinas Announces Retirement of Chief Executive Officer and Succession Plan
Posted On Wednesday, July 09, 2025
Krystal Biotech Announces First Patient Dosed in Phase 1/2 Trial of KB801 for the Treatment of Neurotrophic Keratitis
Posted On Wednesday, July 09, 2025
MEME Coins Inc. Finalizes DOG Token Acquisition from Tipestry Inc.
Posted On Wednesday, July 09, 2025
Purespring Therapeutics announce FDA IND clearance for Phase I/II clinical trial for primary IgA nephropathy (IgAN)
Posted On Wednesday, July 09, 2025
Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock
Posted On Tuesday, July 08, 2025
Revive Therapeutics Clarifies Completion of Key Nerve Agent Countermeasure Study
Posted On Tuesday, July 08, 2025
New ExoPTEN Preclinical Study Indicates Significant Improvement in Walking Quality in Spinal Cord Injury Model
Posted On Tuesday, July 08, 2025
Lixte Biotechnology Holdings, Inc. Announces the Closing of $1.5 Million Registered Direct Offering
Posted On Tuesday, July 08, 2025
Rhythm Pharmaceuticals To Announce Topline Results from Phase 2 Trial Evaluating Oral MC4R Agonist Bivamelagon in Acquired Hypothalamic Obesity
Posted On Tuesday, July 08, 2025
Longeveron® Announces U.S. FDA Approval of IND Application for a Phase 2 Pivotal Registration Study Evaluating Laromestrocel as a Treatment of Pediatric Dilated Cardiomyopathy (DCM)
Posted On Tuesday, July 08, 2025
PathAI Launches Precision Pathology Network to Advance AI-Powered Pathology
Posted On Tuesday, July 08, 2025
Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies
Posted On Tuesday, July 08, 2025
Calidi Biotherapeutics Inc. (NYSE American: CLDI) Developing Precision Genetic Medicine Platform for Cancer Treatment
Posted On Tuesday, July 08, 2025
Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy
Posted On Tuesday, July 08, 2025
BiomX Announces Publication in Nature Communications of Phage Cocktail BX004 Phase 1b/2a Part 1 Data Demonstrating Strong Activity in Cystic Fibrosis
Posted On Tuesday, July 08, 2025
Nuvectis Pharma Announces Successful Completion of a Drug-Drug Interaction Study in Healthy Volunteers Supporting NXP900's Potential as a Combination Partner with Leading Therapies
Posted On Tuesday, July 08, 2025
Humacyte announces Symvess™ ECAT Approval from U.S. Defense Logistics Agency
Posted On Tuesday, July 08, 2025
Beacon Therapeutics completes enrollment in registrational Phase 2/3 VISTA trial of laru-zova for patients with XLRP
Posted On Tuesday, July 08, 2025
Vaxart Announces Trading on OTCQX Best Market
Posted On Tuesday, July 08, 2025
Certara Announces Expansion of Clinical Technology Collaboration with Merck
Posted On Tuesday, July 08, 2025
Plus Therapeutics Announces Initial Patients Successfully Treated in ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases
Posted On Tuesday, July 08, 2025
Upstream Bio Announces First Patient Dosed in Phase 2 Clinical Trial of Verekitug in Chronic Obstructive Pulmonary Disease (COPD)
Posted On Tuesday, July 08, 2025
Larimar Therapeutics Publishes Nonclinical Data Supporting the Therapeutic Potential of Nomlabofusp in Patients with Friedreich’s Ataxia
Posted On Tuesday, July 08, 2025

First page
Previous page
…
4
5
6
7
8
9
10
11
12
…
Next page
Last page

Print